GLP-1 weight-loss medications are intended for adults with obesity or weight-related health conditions — not for cosmetic weight loss. The FDA-aligned criteria: BMI 30 or higher, or BMI 27 or higher with at least one weight-related condition. Check your eligibility in 2 minutes. A licensed Thai doctor reviews your assessment and recommends the right medication path.
Treatments supervised by Dr. Kenika Norrachetdecha
Medical Director · Thai License #72509
● Mon–Sat 8 AM–6 PM · Online consults daily · Reply in 2 Min
Personal consultation included with every program
That's −17.8 kg — you'd weigh .
Based on the 20.9% trial-mean. Individual outcomes vary.FDA and EMA guidance for GLP-1 weight-management therapy uses two BMI thresholds. Most adults seeking treatment qualify under one of them.
Overweight range, with at least one weight-related condition (see conditions grid below).
Obesity class I or higher, no additional conditions required for therapy consideration.
BMI is a starting filter, not the full picture. Dr. Kenika reviews waist circumference, body composition, and metabolic markers before prescribing.
If your BMI is between 27 and 30, you still qualify for GLP-1 therapy when any one of the following co-morbidities is present.
Confirmed T2D diagnosis, HbA1c ≥6.5% or on glucose-lowering therapy.
HbA1c 5.7–6.4% or fasting glucose 100–125 mg/dL.
Sustained BP ≥130/80 mmHg or on antihypertensive medication.
Elevated LDL, low HDL, or triglycerides ≥150 mg/dL.
Diagnosed OSA, AHI ≥5, with or without CPAP therapy.
Non-alcoholic / metabolic-associated fatty liver disease on imaging or biopsy.
Polycystic ovary syndrome with insulin resistance or weight component.
These contraindications are reviewed during the doctor consultation. Absolute contraindications rule out GLP-1 therapy entirely; relative contraindications require careful case-by-case judgement.
Your eligibility consultation determines whether baseline labs are needed based on your medical history. Most patients receive a same-day prescription with medication delivered within 48 hours.
All eligibility and lab decisions are reviewed by Dr. Kenika Tonkam before any GLP-1 prescription is issued.
Most patients move from initial assessment to cold-chain delivery within 5–7 days. No clinic visits required for routine cases.
Quick form: BMI, conditions, medication history. Result delivered the same day.
20-minute video call with Dr. Kenika. Review goals, history, and the right medication choice.
Either fresh draw at a partner lab in Bangkok / Pattaya / Phuket, or upload results from the last 90 days.
Authentic pen delivered same- or next-day. Titration plan and WhatsApp support attached.
Pick your treatment, enter your weights, see your trajectory. All data from peer-reviewed clinical trials. Individual outcomes vary — final program plan determined in private consultation.
Your trajectory · based on clinical-trial mean
Eligibility criteria adapted from FDA labels for Wegovy (semaglutide 2.4 mg), Zepbound (tirzepatide), and Saxenda (liraglutide 3 mg). Absolute contraindications: personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, severe pancreatitis history, current pregnancy, or known hypersensitivity to GLP-1 agonists. Relative considerations: gastroparesis, severe gastrointestinal disease, retinopathy in patients with type 2 diabetes.
Each program is personalized based on your profile, medical history, and goals.
Step 1 of 5
Step 2 of 5
Select all that apply, or "None of these"
Step 3 of 5
Confidential — only your doctor sees this
Step 4 of 5
Step 5 of 5
Dr. Kenika's recommendation for you
Your access
—
Our actual clinic · Real photos
Authentic medications. Direct access to Dr. Kenika. Comprehensive metabolic care beyond GLP-1 alone.
Authentic Medications
Mounjaro, Zepbound (Eli Lilly), Wegovy, Ozempic, Saxenda (Novo Nordisk) — all sourced through the licensed Thai pharmaceutical supply chain.
Direct Doctor Access
WhatsApp Dr. Kenika directly. Every GLP-1 prescription personally supervised by the Medical Director.
Beyond GLP-1
Multi-modal metabolic care: GLP-1 plus hormone optimization, IV recovery, and advanced peptide protocols.
In Thailand for treatment? If your eligibility profile checks out, you can start in-person at our Pattaya GLP-1 program — same-day labs, doctor consultation, first injection.
You're eligible if you have BMI ≥ 30 (obese), or BMI ≥ 27 with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia, OSA, established cardiovascular disease). Adults 18+ only. Dr. Kenika confirms during eligibility consult.
Personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN-2), severe gastroparesis, history of pancreatitis, or pregnancy. These are absolute contraindications per FDA boxed warning.
Most patients don't. Your eligibility consult with Dr. Kenika determines if labs are needed. Patients with diabetes, kidney issues, or known metabolic conditions need baseline labs (HbA1c, kidney function, liver enzymes). Otherwise — prescription same-day.
GLP-1 medications are not indicated for cosmetic weight loss in adults with BMI < 27. If your BMI is in this range, we'll discuss alternative options including nutrition guidance, body-composition tracking, and metabolic optimization.
Most other medications are compatible. Dr. Kenika reviews your full medication list during consultation. Caution with insulin and sulfonylureas (hypoglycemia risk) and warfarin (dose may need adjustment).
Pancreatitis history is a contraindication per the FDA labels. Even decades ago, the risk of re-occurrence with GLP-1 is elevated. We may explore alternative weight-loss approaches in consultation.
Yes — international patients across Europe, UAE, Singapore, Australia. You do labs locally, video-consult with Dr. Kenika, and receive medication via DHL cold-chain. Some countries restrict GLP-1 import — we confirm before shipping.
We tell you upfront and refund any medication payment. The eligibility consult fee (฿1,500–2,000) is non-refundable as it covers the doctor's clinical assessment time. We'll suggest evidence-based alternatives where appropriate.
Licensed
Thai Pharmacy
Pharmaceutical
Grade
Doctor
Supervised
Same-Day
Care
Real reviews from real patients on Google Business Profile. Currently 5.0 ★ from 25 verified reviews — and growing. Reviews are updated regularly.
Peer-reviewed primary sources, FDA prescribing information, and manufacturer documentation.
Additional clinical questions are discussed during your private consultation with Dr. Kenika.
Direct access to Dr. Kenika. Authentic medications. Three access points across Thailand.
Personal medical supervision · Cancel anytime · Authentic medications from Eli Lilly and Novo Nordisk
Book via WhatsApp · Free eligibility check
Each GLP-1 protocol has a different mechanism, trial profile, and outcome ceiling. Compare or explore by location.
Eli Lilly's dual GIP/GLP-1 agonist. Highest trial-mean of any approved GLP-1. Best fit for goals above 15%.
See program →
Novo Nordisk's most-prescribed GLP-1. Excellent track record for goals up to 15%. Built-in outcome estimator.
See program →
Investigational GLP-1/GIP/Glucagon triple agonist. Highest documented mean reduction. Private-consultation program.
See program →
In-person consultation, baseline labs, and same-week start. Walk-in or appointment. Most international patients begin here.
See clinic →This eligibility framework follows FDA labeling for semaglutide (Wegovy) and tirzepatide (Zepbound). Clinical trial inclusion criteria from the STEP-1 trial (Wilding et al., NEJM 2021) and SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) typically required BMI 30 kg/m2 or greater, or BMI 27 with at least one weight-related comorbidity such as hypertension, dyslipidemia, type 2 diabetes, or obstructive sleep apnea. Contraindications include personal or family history of medullary thyroid carcinoma and Multiple Endocrine Neoplasia syndrome type 2.
Last reviewed by Dr. Kenika Tonkam, Medical Director, TRT Bangkok · June 3, 2026
